Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: A population-based study with temporal trends

American Journal of Gastroenterology

Volumn 104, Issue 6, 2009, Pages 1356-1362

  Cooper, Gregory S ^a,b   Kou, Tzyung Doug ^b   Chak, Amitabh ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BARRETT ESOPHAGUS; BILLING AND CLAIMS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 66949175556     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.159     Document Type: Article

References (22)

1. Blot WJ, Devesa SS, Kneller RW et al. Risingincidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Pera M, Cameron AJ, Trastek VF et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
3. Devesa SS, Blot WJ, Fraumeni JF Jr.Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
4. Wang KK, WongkeesongM, Buttar NS. American gastro enterological association medical position statement: role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 2005;128:1468-70.
5. ASGE Standards of Practice Committee. A S GE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006;63:570-80.
6. ASGE Standards of Practice Committee. Role of endoscopy in the management of GERD. Gastrointest Endosc 2007;66:219-24.
7. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008;103:788-97.
8. Corley DA, Levin TR, Habel LA et al. Surveillance an d survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002;122:633-40.
9. Kearney DJ, Crump C, Maynard C et al. A case - control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD. Gastrointest Endosc 2003;57:823-9.
10. Cooper GS, Yuan Z, Chak A et al. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia.Cancer 2002;95:32-8.
11. Potosky AL, Riley G F, Lubitz JD et al. Potential for cancer related h ealth services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-48.
12. Warren JL , Klabunde C N, Schrag D et al. Overview of the SEER-Medicare data. Med Care 2002;40 (Suppl): 3-18.
13. Cooper GS, Virnig B, Klabunde CN et al. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002;40 (Suppl):43-8.
14. Deyo RA, Cherk in DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
15. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data. Med Care 2002;40 (Suppl): 26-35.
16. Rubenstein JH, Sonnenberg A, Davis J et al. Efect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc 2008;68:849-55.
17. El Serag HB, Aguirre TV, Davis S et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barretts esophagus. Am J Gastroenterol 2004;99:1877-83.
18. Ouatu-Lascar R, Fitzgerald RC, Triadaflopoulos G. Diferentiation and proliferation in Barretts esophagus and the effect of acid suppression. Gastroenterology 1999;117:327-35.
19. Sackett DL, Haynes RB, Guyatt GH et al. Clinical Epidemiology: A Basic Science for Clinical Medicine , 2nd edn Little Brown: Boston, 1991.
20. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:42-6.
21. Hampel H, Abraham NS, El Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-21.
22. Cooper GS, Chak A, Lloyd LE et al. The accuracy of diagnosis and procedural codes for patients with upper gastrointestinal hemorrhage. Gastrointest Endosc 2000;51:423-6.